Benefit of Spectral Information in Patients Suspected for Lung Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Benefit of Spectral Information in Patients Suspected for Lung Cancer — Stella

Recruiting

Back to Lung Neoplasm Malignant trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Copenhagen University Hospital Herlev, Herlev, Capital Region

Key details

Sponsor

Copenhagen University Hospital at Herlev

Collaborators

Rigshospitalet, Denmark, Aarhus University Hospital

Enrollment target

~1,000 participants

Started

May 2024

Primary completion

July 2026

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov